Global Antipsychotic Drugs Market is Estimated to Reach $14.5 Billion by 2023, Says Accurize Market Research
Global Antipsychotic Drugs Market report published by Accurize Market Research forecast that the global market is expected to reach $14.5 billion by 2023; growing at a CAGR of 2.1% from 2017 to 2025. By geography, Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.
To browse the complete report, visit at https://www.accurizemarketresearch.com/report/antipsychotic-drugs-market
High pervasiveness of schizophrenia, increased drug abuse and over prescription of drugs to drive the growth of the market
High pervasiveness of schizophrenia, psychotic ailments increased drug abuse and over prescription of drugs fuels the demand for the global antipsychotic drugs market. Furthermore, increasing initiatives by government and addiction to antipsychotic drugs also boosts the growth of the market.
Market Segmentation
The global antipsychotic drugs market has been bifurcated on the basis of mechanism of action, disease indication and geography. Mechanism of action segment is bifurcated as global antipsychotic drug market, d2 antagonists, d2/5ht2a antagonists, and d2 partial agonists. Disease indication segment is further bifurcated asschizophrenia, bipolar disorder, major depressive disorder, and other disease indications agonists. By geography the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Top players in the market
The key players operational in the market includes Acadia Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alexza Pharmaceuticals, Alkermes Plc., Allergan Plc., Apotex, Inc., AstraZeneca Plc., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Eli Lilly and Co. and Gedeon Richter Plc., among others.
Contact Us
Stephen Jones,
Head - Sales
Accurize Market Research
K-129, PC COLONY, HANUMAN NAGAR,
KANKARBAGH, PATNA,
Tel: +91-612-2369997